Signalling protein plays different roles in breast cancer and normal cells

June 20, 2014

A key step in developing effective cancer therapies is identifying differences between normal, healthy cells and cancer cells – these differences can then be exploited to specifically kill tumour cells.

A new study by Manchester scientists has shown for the first time that a particular protein has contrasting effects in normal and cancerous breast – meaning it could prove useful in the development of more targeted treatments for . This protein – known as CXCR4 – has previously been detected in 23 different types of cancer and has been linked to poor prognosis.

Now researchers have investigated the role of CXCR4 in both normal and cancerous breast stem cells – cells that are used for tissue growth and replenishment. The group from The University of Manchester – part of the Manchester Cancer Research Centre – found that the protein controls repeated replication of breast cancer stem cells and has a potential role in cancer spread.

Dr Rob Clarke, who led the research, said: "We know that CXCR4 controls stem cells in lung, pancreatic and prostate cancer. It is also linked to poor prognosis in breast cancer. However, we wanted to better understand the role that CXCR4 plays in breast stem cells."

In a study published in the journal Oncotarget, the team show that there were increased levels of CXCR4 in breast stem cells. However, only in did the protein control the growth of new cells.

"The differing role of this molecule in healthy and cancerous tissue is potentially very interesting and could be used to specifically target but we still need to learn more about the underlying basis for these observed differences," added Dr Clarke.

Explore further: Researchers identify new protein linked to leukaemia growth

More information: "A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity." Ablett et al. Oncotarget. 2014 Feb 15;5(3):599-612.

Related Stories

Researchers identify new protein linked to leukaemia growth

May 16, 2014
(Medical Xpress)—Their work has identified a protein called PIP4K2A that could be a new target in drug development.

Stopping the spread of breast cancer

June 3, 2014
The primary cause of death from breast cancer is the spread of tumor cells from the breast to other organs in the body. Northwestern Medicine® scientists have discovered a new pathway that can stop breast cancer cells from ...

A transcription factor called SLUG helps determines type of breast cancer

May 2, 2014
During breast-tissue development, a transcription factor called SLUG plays a role in regulating stem cell function and determines whether breast cells will mature into luminal or basal cells.

Potential cholesterol lowering drug has breast cancer fighting capabilities

June 17, 2014
Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of breast cancer, but also can kill the cancerous cells.

Long-lived breast stem cells could retain cancer legacy

January 26, 2014
Researchers from Melbourne's Walter and Eliza Hall Institute have discovered that breast stem cells and their 'daughters' have a much longer lifespan than previously thought, and are active in puberty and throughout life.

New breast cancer stem cell findings explain how cancer spreads

January 14, 2014
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes ...

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.